Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients

M Martinot1, M Eyriey2, S Gravier1

  • 1Infectious Diseases Department, Hôpitaux Civils, 39, avenue de la liberté, 68024 Colmar, France.

Insights

Severe COVID-19 in France led to significant ICU admissions and deaths. Key risk factors included older age, male sex, comorbidities, and elevated inflammatory markers, with frequent extrapulmonary complications observed.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Epidemiology

Background:

  • A significant coronavirus disease 2019 (COVID-19) outbreak occurred in Northeastern France during spring 2020.
  • Understanding risk factors and complications is crucial for managing severe COVID-19 cases.

Purpose of the Study:

  • To compare severe versus non-severe COVID-19 patients.
  • To identify risk factors for intensive care unit (ICU) hospitalization and death.
  • To describe the frequency of extrapulmonary complications in COVID-19 patients.

Main Methods:

  • Retrospective observational cohort study of 600 patients admitted to Colmar Hospital in March 2020.
  • Analysis of baseline characteristics, comorbidities, and clinical outcomes.
  • Comparison between survivors and non-survivors, and between ICU and non-ICU patients.

Main Results:

  • 19.1% of patients died, and 25.5% required ICU admission.
  • Independent risk factors for death included older age, male sex, chronic diseases, and elevated C-reactive protein (CRP) and creatinine.
  • Frequent extrapulmonary complications included acute renal injury (13.3%), cardiovascular events (5.5%), and venous thromboembolism (4%).

Conclusions:

  • Older age, male sex, comorbidities, and inflammatory markers are significant predictors of mortality in severe COVID-19.
  • Extrapulmonary complications are common, particularly in ICU patients.
  • This study provides critical insights into COVID-19 severity and outcomes in the French outbreak.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
539
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.0K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
434
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
529
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.9K